HC Surgical Specialists Limited (SGX:1B1)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.3300
+0.0050 (1.54%)
At close: Sep 2, 2025
1.54%
Market Cap50.61M
Revenue (ttm)19.19M
Net Income (ttm)8.44M
Shares Out153.38M
EPS (ttm)0.05
PE Ratio6.01
Forward PEn/a
Dividend0.02 (7.26%)
Ex-Dividend Daten/a
Volume27,000
Average Volume82,720
Open0.3300
Previous Close0.3250
Day's Range0.3300 - 0.3300
52-Week Range0.2600 - 0.3550
Beta0.04
RSI53.19
Earnings DateJul 25, 2025

About HC Surgical Specialists

HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other g... [Read more]

Industry Offices and Clinics of Doctors of Medicine
Founded 2015
Country Singapore
Stock Exchange Singapore Exchange - Catalist
Ticker Symbol 1B1
Full Company Profile

Financial Performance

In 2025, HC Surgical Specialists's revenue was 19.19 million, an increase of 0.71% compared to the previous year's 19.05 million. Earnings were 8.44 million, an increase of 119.42%.

Financial Statements

News

There is no news available yet.